Clinical Trial Update: A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dasotraline for safety and effectiveness in adults with moderate to severe binge eating disorder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder

Drugs mentioned

• Dasotraline (dasotraline)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Binge Eating Disorder | Phase 3 | Status: COMPLETED | Results posted: 2020-07-13